The primary focus of the Cell Death Regulation Group at IDIBELL is to understand how cells die when they lack essential nutrients and how they communicate with the tissue. Their aim is to use this knowledge to develop better therapies for cancer treatment or against ischemic diseases such as stroke. They are an international group with numerous local and international collaborations in the fields of cell death, the immune response and cancer metabolism.
Bellvitge Biomedical Research Institute (IDIBELL)
Hospital Duran i Reynals, 3a planta
Gran Via de l’Hospitalet, 199
08908 L’Hospitalet del Llobregat
Barcelona, Spain
T +34 932607130
Contact e-mail
Visit website
As part of our MSCA-ESR training on complementary skills we got to leave the wet lab to explore what happens on the other side of the bench and to learn what it means to be a scientific editor. This is our story.
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement No 766214.
Bellvitge Biomedical
Research Institute (IDIBELL)
Hospital Duran i Reynals, 3a planta
Gran Via de l’Hospitalet, 199
08908 L’Hospitalet del Llobregat
Barcelona, Spain
